If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
377.50    2.50 (0.67%)
Bid:
374.50
Ask:
376.50
Spread: 2.00 (0.534%)
Market Cap: £1.93b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

8 Jan 2019 15:40

RNS Number : 5327M
Caledonia Investments PLC
08 January 2019
 

Caledonia Investments plc

Director/PDMR Shareholding Notification

 

Caledonia Investments plc ("Caledonia") has been notified pursuant to the requirements of the EU Market Abuse Regulation of the following transactions involving two of its directors, Jamie Cayzer-Colvin and William Wyatt, as detailed below.

 

On 8 January 2019, ordinary 5p shares were transferred to the above-named directors under Caledonia's 2011 Performance Share Scheme ("Performance Share Scheme") and Caledonia's 2011 Deferred Bonus Plan ("Deferred Bonus Plan") at nil cost. All shares were sourced from the Caledonia Investments plc Employee Share Trust ("EST") and subsequently sold back to the EST at 2907.5p per share on the same date.

 

 

No of shares transferred under the Performance Share Scheme at £nil

 

No of shares transferred under the Deferred Bonus Plan at £nil

 

No of shares sold

% of issued capital

JMB Cayzer-Colvin

 

14,358

10,670

25,028

0.05

WP Wyatt

 

23,352

17,784

41,136

0.07

 

 

Further information required by the EU Market Abuse Regulation in relation to these transactions is set out in the appendix below.

 

Enquiries:

Mrs K M Burwood

Deputy Company Secretary

Caledonia Investments plc

+ 44 20 7802 8080

8 January 2019

 

 

APPENDIX 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

James Michael Beale Cayzer-Colvin

2

 

Reason for the notification

 

a)

 

Position/status

 

Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

GB0001639920

b)

 

Nature of the transaction

 

 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares arising from 1 and 2 above

 

c)

 

 

Price(s) and volume(s)

 

1. Exercise of PSS awards

 

2. Call of DBP awards

 

3. Sale of shares

 

 

Price(s)

 

Volume(s)

£0.00

14,358

£0.00

 

10,670

 

£29.075

25,028

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

25,028 shares

 

Exercise of PSS awards/Call of DBP awards (£nil)

 

Sale of shares: £29.075

 

e)

 

Date of the transaction

 

8 January 2019

f)

 

Place of the transaction

 

 

Exercise of PSS and call of DBP awards - outside a trading venue

Sale of shares - London Stock Exchange XLON

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

William Penfold Wyatt

2

 

Reason for the notification

 

a)

 

Position/status

 

Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

GB0001639920

b)

 

Nature of the transaction

 

 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares arising from 1 and 2 above

 

 

c)

 

 

Price(s) and volume(s)

 

1. Exercise of PSS awards

 

2. Call of DBP awards

 

3. Sale of shares

 

 

Price(s)

 

Volume(s)

£0.00

 

23,352

 

£0.00

17,784

£29.075

41,136

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

41,136 shares

 

Exercise of PSS awards/Call of DBP awards (£nil)

 

Sale of shares: £29.075

 

e)

 

Date of the transaction

 

8 January 2019

f)

 

Place of the transaction

 

 

Exercise of PSS awards and call of DBP awards - outside a trading venue

Sale of shares - London Stock Exchange XLON

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHSSAFIAFUSEDF
Date   Source Headline
5th Mar 202610:30 amRNSNet Asset Value(s)
5th Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20264:37 pmRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20269:57 amRNSDirector/PDMR Shareholding
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 202611:00 amRNSNet Asset Value(s)
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 202610:30 amRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSFunds spotlight event
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 202611:36 amRNSDirector/PDMR Shareholding
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 202611:00 amRNSAppointment of non-executive director
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20263:00 pmRNSDirector/PDMR Shareholding
12th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSNet Asset Value(s)
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.